Crossmark

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials

Crossref DOI link: https://doi.org/10.1186/s13054-019-2446-1

Published Online: 2019-05-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Santhakumaran, Shalini

Gordon, Anthony

Prevost, A. Toby

O’Kane, Cecilia

McAuley, Daniel F.

Shankar-Hari, Manu http://orcid.org/0000-0002-5338-2538
Funding

Funding for this research was provided by:

Efficacy and Mechanism Evaluation Programme (16/33/01)

Research Trainees Coordinating Centre (NIHR-CS-2016-16-011, RP-2015-06-018)
License Information

Text and Data Mining valid from 2019-05-03
More Information

Article History

Received: 21 January 2019

Accepted: 15 April 2019

First Online: 3 May 2019

Ethics approval and consent to participate

: We obtained ethics approval for this study (18/LO/1079).

: We obtained consent to publish non-identifiable data.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below